K. Katayama

528 total citations
9 papers, 66 citations indexed

About

K. Katayama is a scholar working on Neurology, Hematology and Genetics. According to data from OpenAlex, K. Katayama has authored 9 papers receiving a total of 66 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Neurology, 3 papers in Hematology and 2 papers in Genetics. Recurrent topics in K. Katayama's work include Peripheral Neuropathies and Disorders (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Bone and Joint Diseases (1 paper). K. Katayama is often cited by papers focused on Peripheral Neuropathies and Disorders (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Bone and Joint Diseases (1 paper). K. Katayama collaborates with scholars based in Japan and Czechia. K. Katayama's co-authors include Yasunori Sato, Sonoko Misawa, Satoshi Kuwabara, Yuta Iwai, Yukari Sekiguchi, Hiroshi Amino, Hideki Hanaoka, Kazumoto Shibuya, Minako Beppu and Masahiro Takeuchi and has published in prestigious journals such as Annals of the Rheumatic Diseases, BMJ Open and Clinical Nutrition.

In The Last Decade

K. Katayama

6 papers receiving 66 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Katayama Japan 4 51 23 21 13 8 9 66
Sébastien Gazzola France 4 39 0.8× 14 0.6× 7 0.3× 8 0.6× 7 0.9× 7 67
A.F. Serre France 3 34 0.7× 7 0.3× 14 0.7× 15 1.2× 5 0.6× 3 48
J. Valls Spain 4 51 1.0× 10 0.4× 21 1.0× 29 2.2× 4 0.5× 6 94
Angelo Maurizio Clerici Italy 7 125 2.5× 73 3.2× 7 0.3× 19 1.5× 6 0.8× 11 142
Youssef Sidhom Tunisia 6 81 1.6× 7 0.3× 24 1.1× 54 4.2× 8 1.0× 21 141
Fu Liong Hiew Malaysia 9 186 3.6× 105 4.6× 14 0.7× 19 1.5× 5 0.6× 33 211
Rashad Jabarkheel United States 5 20 0.4× 6 0.3× 5 0.2× 13 1.0× 9 1.1× 24 85
John‐Philip Lawo United States 6 100 2.0× 80 3.5× 17 0.8× 16 1.2× 6 0.8× 15 142
M. Dib France 5 20 0.4× 13 0.6× 20 1.0× 3 0.2× 15 1.9× 7 47
Mafalda Seabra Portugal 4 42 0.8× 6 0.3× 3 0.1× 23 1.8× 12 1.5× 14 68

Countries citing papers authored by K. Katayama

Since Specialization
Citations

This map shows the geographic impact of K. Katayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Katayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Katayama more than expected).

Fields of papers citing papers by K. Katayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Katayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Katayama. The network helps show where K. Katayama may publish in the future.

Co-authorship network of co-authors of K. Katayama

This figure shows the co-authorship network connecting the top 25 collaborators of K. Katayama. A scholar is included among the top collaborators of K. Katayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Katayama. K. Katayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Katayama, K., Kazuo Tanaka, Yuichi Mochida, et al.. (2023). AB0507 FILGOTINIB MAY BE USEFUL THERAPY FOR RAPID RADIOGRAPHIC PROGRESSION BY REDUCING BONE EDEMA. Annals of the Rheumatic Diseases. 82. 1448–1448.
2.
Tanaka, Kazuhiro, et al.. (2023). AB0469 BASELINE MODIFIED TOTAL SHARP SCORE MAY BE A PREDICTOR FOR FLARE AND SUCCESSIVE JOINT DAMAGE IN TAPERING OF METHOTREXATE. Annals of the Rheumatic Diseases. 82. 1427–1428.
3.
Suichi, Tomoki, Sonoko Misawa, Kengo Nagashima, et al.. (2020). Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial. Internal Medicine. 59(9). 1149–1153. 9 indexed citations
5.
Yoshitama, Tamami, Tetsu Oyama, Akira Sagawa, et al.. (2017). AB1187 Survey on generic drugs (GE) and bio-similar drugs (BIO-S) of patients with rheumatoid arthritis (RA) and their doctors - cohort study of the japanese clinician biologics research group. Annals of the Rheumatic Diseases. 76. 1471–1471. 1 indexed citations
6.
Misawa, Sonoko, Yasunori Sato, K. Katayama, et al.. (2015). Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. BMJ Open. 5(11). e009157–e009157. 40 indexed citations
7.
Katayama, K., Sonoko Misawa, Yasunori Sato, et al.. (2015). Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open. 5(1). e007330–e007330. 10 indexed citations
9.
Katayama, K., et al.. (1981). [Intracranial hemorrhage due to vitamin K deficiency in infants: its importance as a cause of intracranial hemorrhage in infants (author's transl)].. PubMed. 33(10). 989–97. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026